Skip to main content
. 2019 Jan 15;20(2):327. doi: 10.3390/ijms20020327
ABG Arterial blood gases
BAL Bronchoalveolar lavage
BMI Body mass index
CT Computed tomography
DLCO Diffusion capacity for carbon monoxide
EPAP Expiratory positive airway pressure
ERT Enzyme replacement therapy
FEV1 Forced expiratory volume in the first second
FVC Forced vital capacity
GAA Acid alpha-glucosidase
GAG Glycosaminoglycans
Gb3 Globotriaosylceramide
GBA Acid beta-glucosidase or glucosylceramidase
GSD II Glycogen storage disease type II
HRCT High-resolution computed tomography
HSCT Hematopietic stem-cell transplantation
IPAP Inspiratory positive airway pressure
LDL Low-density lipoprotein
LOPD Late-onset Pompe disease
LSD Lysosomal storage diseases
Lyso-Gb3 Globotriaosylsphingosine
MEP Maximum expiratory pressure
MIP Maximum inspiratory pressure
ML Mucolipidosis
MPS Mucopolysaccharidosis
MRI Magnetic resonance imaging
MV Mechanical ventilation
MVV Maximum voluntary ventilation
NIV Non-invasive ventilation
NPC Niemann-Pick disease type C
OSA Obstructive sleep apnea
PaCO2 Partial pressure of carbon dioxide in arterial blood
PCF Peak cough flow
PFTs Pulmonary function tests
PSG Polysomnography
REM Rapid eye movement
SDB Sleep-disordered breathing
SNIP Sniff nasal inspiratory pressure
SRT Substrate reduction therapy
VC Vital capacity